We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+12.75%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$104B
AUM Growth
+$8.72B
Cap. Flow
-$256M
Cap. Flow %
-0.25%
Top 10 Hldgs %
26.49%
Holding
4,372
New
62
Increased
2,195
Reduced
1,544
Closed
71

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$35.4M
2
P
Everpure Inc
P
+$21M
3
NVDA icon
NVIDIA
NVDA
+$20.7M
4
AMH icon
American Homes 4 Rent
AMH
+$19.3M
5
DAY
Dayforce
DAY
+$19M

Sector Composition

Rank Sector Weight
1 Technology 28.42%
2 Financials 13.09%
3 Healthcare 11.94%
4 Consumer Discretionary 10.95%
5 Industrials 9.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EXK
3626
Endeavour Silver
EXK
$2.83B
$3.09K ﹤0.01%
1,282
STN icon
3627
Stantec
STN
$8.39B
$3.07K ﹤0.01%
37
+27
+270% +$2.22K
SCX
3628
DELISTED
The L.S. Starrett Company
SCX
$3.05K ﹤0.01%
192
CCM
3629
Concord Medical Services
CCM
$19.7M
$3.02K ﹤0.01%
546
VEON icon
3630
VEON
VEON
$3.95B
$3K ﹤0.01%
+125
New +$2.78K
AHI
3631
DELISTED
Advanced Health Intelligence Ltd
AHI
$2.95K ﹤0.01%
1,965
GP
3632
GreenPower Motor Co
GP
$11M
$2.95K ﹤0.01%
150
FARM
3633
DELISTED
Farmer Brothers
FARM
$2.86K ﹤0.01%
800
ABVX
3634
Abivax
ABVX
$11.4B
$2.85K ﹤0.01%
+199
New +$2.57K
CCJ icon
3635
Cameco
CCJ
$42.4B
$2.81K ﹤0.01%
65
CTMX icon
3636
CytomX Therapeutics
CTMX
$754M
$2.81K ﹤0.01%
1,291
BIP icon
3637
Brookfield Infrastructure Partners
BIP
$18B
$2.81K ﹤0.01%
90
WAVE
3638
Eco Wave Power Global
WAVE
$43.3M
$2.75K ﹤0.01%
2,640
+1,625
+160% +$2.28K
KRON
3639
DELISTED
Kronos Bio
KRON
$2.71K ﹤0.01%
2,088
LIVE icon
3640
Live Ventures
LIVE
$29.6M
$2.7K ﹤0.01%
100
BHM icon
3641
Bluerock Homes Trust
BHM
$34.9M
$2.66K ﹤0.01%
157
ASYS icon
3642
Amtech Systems
ASYS
$272M
$2.66K ﹤0.01%
492
TRML
3643
DELISTED
Tourmaline Bio
TRML
$2.66K ﹤0.01%
116
LUXE
3644
LuxExperience B.V.
LUXE
$1.11B
$2.65K ﹤0.01%
835
ASMB icon
3645
Assembly Biosciences
ASMB
$529M
$2.65K ﹤0.01%
199
-1
-0.5% -$12
IMRN
3646
Immuron
IMRN
$8.31M
$2.62K ﹤0.01%
+1,010
New +$2.17K
HYZN
3647
DELISTED
Hyzon Motors Inc. Class A Common Stock
HYZN
$2.55K ﹤0.01%
69
NBP
3648
NovaBridge Biosciences American Depositary Shares
NBP
$202M
$2.55K ﹤0.01%
1,371
BIVI icon
3649
BioVie
BIVI
$7.54M
$2.54K ﹤0.01%
48
+1
+2% +$103
CMCM
3650
Cheetah Mobile
CMCM
$96.5M
$2.46K ﹤0.01%
816

Similar funds

RhumbLine Advisers's Q1 2024 Portfolio in Review

As of Q1 2024, RhumbLine Advisers held 4,372 positions worth $104B, up 9.1% from $95.4B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Trading was light in Q1 2024: portfolio turnover was 3%. RhumbLine Advisers opened 62 new positions and exited 71, leaving the 4,372-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 28% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q1 2024 buy was Dayforce: 278,394 shares worth $18.4M.
  • RhumbLine Advisers added most to Amazon in Q1 2024, an estimated $35.4M increase.
  • RhumbLine Advisers's biggest Q1 2024 reduction was Procter & Gamble, cutting an estimated $46.7M.
  • RhumbLine Advisers fully exited Splunk Inc in Q1 2024, selling an estimated $32.3M.
  • RhumbLine Advisers's ten largest holdings make up 26% of its $104B portfolio in Q1 2024.
  • RhumbLine Advisers opened 62 new positions and closed 71 in Q1 2024.
  • RhumbLine Advisers's portfolio value rose 9.1% quarter-over-quarter to $104B.

Based on RhumbLine Advisers's 13F filing for Q1 2024, filed 9 May 2024.